Trimi Health vs Lean Meds
An annual plan paid in advance against a prepay ladder with rungs.
Trimi Health
Editorial
$99/mo
Trimi Health advertises $99 a month for compounded semaglutide and $125 for compounded tirzepatide, and bills both as an annual plan: $1,188 and $1,500, charged up front or split through a buy-now-pay-later provider. The rate is stated as flat across doses.
Pick it for: Readers ready to pay twelve months in advance
Lean Meds
Editorial
$79/mo
Lean Meds runs a prepay ladder on both molecules: compounded semaglutide is $79 month to month, $76 on three months, $73 on six and $69 on twelve, and compounded tirzepatide steps the same way from $109 down to $95. The rate is flat across doses, so the ladder, and not the dose, is what moves the monthly figure.
Pick it for: Readers who want to choose how much term to buy
Our verdict
Trimi Health bills a year up front at $99. LeanMeds publishes a prepay ladder and states its dosing is flat. Both reward commitment; only one asks for all of it at once.
What actually separates them
Trimi Health and Lean Meds state different things about published price. Everything else they publish, they publish the same way.
Trimi Health costs $20 more than Lean Meds — 25% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $948 at Lean Meds against $1,188 at Trimi Health — a difference of $240.
| Trimi Health | Lean Meds | |
|---|---|---|
| Published price | $99/mo | $79/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.